ASLAN Pharmaceuticals
(NASDAQ) ASLN
ASLAN Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$12.00M
Net Income (TTM)
$35.03M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ASLN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ASLAN Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
35
CEO
Carl Aslan Jason Morton Firth, PhD, EMBA
Website
www.aslanpharma.comHeadquarters
Singapore, 239920, SG
ASLN Financials
Key Financial Metrics (TTM)
Gross Margin
97%
Operating Margin
-4%
Net Income Margin
-4%
Return on Equity
18%
Return on Capital
-4%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$11.65M
Operating Income
$43.74M
EBITDA
$39.40M
Operating Cash Flow
$46.36M
Capital Expenditure
$10.78K
Free Cash Flow
$46.37M
Cash & ST Invst.
$21.25M
Total Debt
$26.83M
ASLAN Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
35
N/A
Net Income
$9.92M
+48.1%
EBITDA
$9.25M
+48.5%
Quarterly Fundamentals
Net Cash
$8.27M
-142.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$19.35M
-28.8%
Short Term Debt
$7.32M
-31.9%
Return on Assets
-1.80%
N/A
Return on Invested Capital
-3.80%
N/A
Free Cash Flow
$0.00
N/A
Operating Cash Flow
$0.00
N/A